FIBROSTENOTIC CROHN'S DISEASE
Clinical trials for FIBROSTENOTIC CROHN'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new FIBROSTENOTIC CROHN'S DISEASE trials appear
Sign up with your email to follow new studies for FIBROSTENOTIC CROHN'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Crohn's patients: drug may prevent bowel surgery
Disease control OngoingThis study tests an experimental drug called AGMB-129 in about 100 people with Crohn's disease who have painful bowel narrowing (strictures). The goal is to see if the drug is safe and can help reduce the narrowing, potentially avoiding the need for surgery. Participants receive …
Matched conditions: FIBROSTENOTIC CROHN'S DISEASE
Phase: PHASE2 • Sponsor: Agomab Spain S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug targets scarring in Crohn's – first look in humans
Knowledge-focused OngoingThis early-phase study tests an experimental drug called PALI-2108 in a small group of people with fibrostenotic Crohn's disease, a condition where the gut becomes scarred and narrow. The main goal is to see how the drug affects inflammation and scarring at the molecular level by…
Matched conditions: FIBROSTENOTIC CROHN'S DISEASE
Phase: PHASE1 • Sponsor: Palisade Bio • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC